Biotechnological Approaches for the Treatment of Inflammatory Diseases

Author(s): V. Iansante, D. Capece, S. Murgo, M. M. Mancarelli, F. Zazzeroni, E. Alesse

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents)

Volume 8 , Issue 1 , 2009

Become EABM
Become Reviewer


Chronic inflammation represents a key pathogenetic event of many diseases, such as psoriasis, inflammatory bowel diseases, rheumatoid arthritis, asthma, multiple sclerosis, atherosclerosis, cystic fibrosis, and sepsis. Conventional therapies for many of these disorders do not lead to the resolution of the inflammatory disorder, and frequently are associated with limited effectiveness and severe side effects. For these reasons alternative therapies have been developed, in the attempt to ensure a more sustained therapeutic response. Biotechnological approaches for the development of these novel drugs are giving exciting results: several biologic molecules are now tested in preclinical or clinical trials, and several of them are even approved for marketing.

Keywords: Inflammatory diseases, recombinant proteins, nucleic acid-based therapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [51 - 71]
Pages: 21
DOI: 10.2174/187152309787580793

Article Metrics

PDF: 21